Podcasts about Bardia

In this AI-generated episode of Radiology AI Papers in a Capsule, we discuss a study that extends the NeuroHarmony AI model to address scanner variability in brain MRI for Alzheimer's disease assessment. Learn how incorporating cognitive status into harmonization may improve the reliability of quantitative imaging across diverse clinical settings. A Machine Learning Model to Harmonize Volumetric BrainMRI Data for Quantitative Neuroradiologic Assessment ofAlzheimer Disease. Archetti and Venkatraghavan et al. Radiology: Artificial Intelligence 2025; 7(1):e240030.

Dr. Dana Alkhulaifat explores how mentorship can inspire and guide the next generation of leaders in radiology and imaging informatics. Guests Dr. Tessa Cook and Satvik Tripathi share insights on building awareness, creating opportunities, and the impact of strong mentor-mentee relationships.

We break down the infamous call from Bill Kelhoffer to Gil—the one that sparked his breakup with his fiancé. Oh Jezuz shares his suspicious First Friday encounter with Raees Mohammed, followed shortly by a mysteriously shattered car window. Days later, Jezuz receives a late-night email from Raees accusing him of mocking the court. Meanwhile, Brandon's depositions are due within the next 30 days. Also… Happy Birthday, Bardia! It's DEPOSITION TIME!

Dr. Jason Adelberg talks with Dr. John Stewart about how he built rScriptor, a radiology dictation tool, from a personal side project into a widely adopted software product. Dr. Stewart shares lessons on entrepreneurship, product development, and how radiologists can turn their own ideas into real businesses.

In this episode, hosts Dr. Cody Savage and Dr. Ali Tejani speak with Dr. Pranav Rajpurkar and Dr. Michael Moritz about the future of AI in radiology, from research breakthroughs to real-world implementation. They discuss building AI models that detect every disease, the challenges of integrating AI into clinical workflows, and the entrepreneurial journey of bringing cutting-edge technology to medical imaging.

In a recent episode of Oncology on the Go, several oncologists discussed the impact of the COVID-19 pandemic on oncology care, 5 years later. Each doctor discussed a different aspect of multidisciplinary care, including medical oncology, radiation oncology, and epidemiology. CancerNetwork® spoke with leading clinicians including:  ·      Aditya Bardia, MD, MPH, FSCO, professor in the Department of Medicine, Division of Hematology/Oncology, and director of Translational Research Integration at the University of California Los Angeles Health Jonsson Comprehensive Cancer Center; ·      Ritu Salani, MD, director of Gynecologic Oncology at the University of California Los Angeles, and ONCOLOGY® editorial advisory board member; ·      Scarlett Lin Gomez, PhD, MPH, a professor in the Department of Epidemiology and Biostatistics at the University of California San Francisco (UCSF), and co-leader of the Cancer Control Program at UCSF Helen Diller Family Comprehensive Cancer Center ·      Marwan F. Fakih, MD, professor in the Department of Medical Oncology & Therapeutics Research, associate director for Clinical Sciences, medical director of the Briskin Center for Clinical Research, division chief of GI Medical Oncology, and co-director of the Gastrointestinal Cancer Program at City of Hope Comprehensive Cancer Center; ·      Elizabeth Zhang-Velten, MD, a radiation oncologist at Keck Medicine of University of Southern California;  ·      Frances Elain Chow, MD, neuro-oncologist at the University of Southern California (USC) Norris Comprehensive Cancer Center ·      James Yu, MD, MHS, FASTRO, assistant professor adjunct, Department of Radiation Oncology, Smilow Cancer Hospital at Saint Francis Hospital, and ONCOLOGY® editorial advisory board member.  The COVID-19 pandemic disrupted routine cancer care in a number of ways. Many patients were unable to receive timely screening, diagnosis, and treatment, Fakih noted. Additionally, Bardia stated that the pandemic led to a decrease in the number of patients participating in clinical trials. One of the most significant changes in oncology care, according to Salani, has been the increased use of telehealth. Telehealth has allowed patients to receive care from the comfort of their own homes, which has been especially beneficial for patients who live in rural areas or who have difficulty traveling. Telehealth has also made it easier for patients to connect with their doctors and to receive support from other members of their care team.  For Gomez, the COVID-19 pandemic also highlighted the importance of addressing the structural and social drivers of health. These are the conditions in which people are born, grow, live, work, and age that can affect their health. For example, people who live in poverty or who lack access to healthy food are more likely to develop cancer. The pandemic has led to a renewed focus on addressing these disparities. Overall, the COVID-19 pandemic has had a profound impact on oncology care. However, it has also led to a number of positive changes, such as the increased use of telehealth and the focus on addressing the structural and social drivers of health. In the years to come, it will be important to continue to build on these changes in order to improve the lives of patients with cancer.

In today's episode, we had the pleasure of speaking with Aditya Bardia, MD, MPH, FASCO, about the FDA approval of fam-trastuzumab deruxtecan-nxki (T-DXd; Enhertu) for the treatment of adult patients with unresectable or metastatic, hormone receptor–positive, HER2-low or -ultralow breast cancer, as determined by an FDA-approved test, that has progressed on at least 1 endocrine therapy in the metastatic setting. Dr Bardia serves as a professor in the Department of Medicine in the Division of Hematology/Oncology and is the director of Translational Research Integration at the UCLA Health Jonsson Comprehensive Cancer Center. In our exclusive interview, Dr Bardia discussed the significance of this approval, findings from the pivotal DESTINY-Breast06 trial (NCT04494425), and what this new indication for T-DXd means for the future of HER2 testing in breast cancer.

Join hosts Dr. Paul Yi and Dr. Ali Tejani as they welcome new team members Dr. Bardia Khosravi and Dr. Cody Savage to discuss the rise of AI-generated podcasts and their impact on radiology education. From Google's Notebook LM to the challenges of AI hallucinations, they explore the future of automated content creation and what it means for the Radiology Artificial Intelligence Podcast.

#MiR - Menschen im Rechtsstaat Dr. Bardia Razavi, Richter am Amtsgericht Hamburg, im Interview Was ist das erste Wort, das uns zum Thema Rechtsstaat einfällt? Welche GG-Artikel lieben wir besonders und wann profitieren wir von unserem Rechtsstaat? Wo sehen wir uns selbst - beruflich wie privat - in der Pflicht und für welches rechtsstaatliche Thema wünschen wir uns mehr Aufmerksamkeit? Welchen Beitrag leistest Du, als Mensch, als Bürger, privat oder in Deinem Beruf? Last but not least: Unsere Message, die wir just in dieser Sekunde loswerden wollen. Wir sollten im Umgang miteinander vielleicht ein wenig abrüsten. Ich habe das Gefühl, dass wir ein wenig das Augenmaß dafür verlieren, was wir anderen teilweise antun, wenn wir so reden und schreiben, wie wir es tun. Ich glaube, unsere Gesellschaft ist jetzt gerade in einer Lage, in der das unter Umständen dazu führen kann, dass nachhaltige Narben bleiben. Von #MiR zu Dir aufs Ohr!

In our exclusive interview, Dr Bardia discussed the significance of this approval, pivotal findings from the phase 3 TROPION-Breast01 trial (NCT05104866), the clinical relevance of being able to improve progression-free survival and quality of life with Dato-DXd compared with standard chemotherapy, and key considerations for sequencing antibody-drug conjugates.

In this episode of Targeted Talks, Aditya Bardia, MD, MPH, FASCO, discusses the recent FDA approval of datopotamab deruxtecan for the treatment of patients with unresectable or metastatic hormone receptor-positive, HER2-negative breast cancer who have received prior systemic therapy.

In this AI-generated episode of Radiology AI Papers in a Capsule, we explore a groundbreaking study on AI-integrated mammography screening. This research, conducted by Elhakim and colleagues from Odense University Hospital, examines how artificial intelligence can optimize screening workflows while maintaining diagnostic accuracy. We break down the study's three integration scenarios, their impact on workload reduction, and the clinical significance of AI-assisted double reading. Tune in for an insightful, AI-curated discussion on the evolving role of AI in radiology. AI-integrated Screening to Replace Double Reading of Mammograms: A Population-wide Accuracy and Feasibility Study. Elhakim et al. Radiology: Artificial Intelligence 2024; 6(6):e230529.

Wie lässt man los, wenn das Herz festhält? Das Jahresende ist der perfekte Zeitpunkt, um zurückzublicken und bewusst loszulassen, was uns nicht mehr guttut. Klingt simpel, oder? In Wahrheit verbirgt sich dahinter eine der größten Herausforderungen im Leben. Ob gescheiterte Beziehung, ein Traum, der nie wahr wurde, oder der Abschied von einem geliebten Menschen - wir hängen lange an Vergangenem, weil es uns vertraut ist. Dabei schleppen wir manchmal emotionalen Ballast mit uns herum, der uns den Blick nach vorne verstellt. Loslassen heißt nicht vergessen oder aufgeben. Es heißt, Raum zu schaffen für das, was noch kommen darf. Ja, das tut weh, macht Angst und fühlt sich anfangs an wie ein freier Fall. Aber genau in diesem Loslassen liegt die Chance, zu wachsen und sich neu zu (er)finden. Was passiert, wenn wir loslassen? Wie erkennen wir, wann die Zeit wirklich reif ist, einen Neuanfang zu wagen? Und wie gelingt diese Aufgabe nachhaltig? Host Niki Löwenstein spricht in dieser Folge mit dem Vitalpsychologen und Autor Bardia Monshi über diesen heilsamen, aber oft schwierigen Prozess. Bardia bringt wertvolle psychologische Tipps und seine ganz persönlichen Erfahrungen mit. In seinem Institut für Vitalpsychologie in Wien-Hietzing hilft er Menschen, Blockaden zu lösen und mutig nach vorne zu blicken. Wie eng sind Krisen und das Loslassen miteinander verknüpft? Warum halten wir oft fest an Dingen, die uns eigentlich belasten? Der leidenschaftliche Hunde-Papa erklärt, welche mentalen Blockaden und typischen Denkfehler uns daran hindern, loszulassen, und wie wir bewusst Raum für Neues schaffen können.  In dieser Folge gibt uns der Experte konkrete Techniken an die Hand, um Ängste vor einem Neuanfang zu überwinden. Und er erzählt, warum Perspektivenwechsel – manchmal auch mit einem flauschigen Vierbeiner – oft der Schlüssel zur Veränderung sind.  Eine inspirierende Folge für alle, die bereit sind, Ballast bewusst gehen zu lassen und mit neuer Energie ins kommende Jahr zu starten. Denn Veränderung bedeutet Leben – und jeder Neuanfang beginnt mit einem ersten Schritt. Was wir außerdem aus dieser Folge mitnehmen: ·     Ob Loslassen passiv oder aktiv ist ·     Wie man Schritte zu mehr Gelassenheit setzt ·     Wie gesunde Trauer funktioniert ·     Warum man nach der Selbstakzeptanz am besten am Schlüsselbein sucht ·     Warum wir den Wunsch nach „Abschalten“ vergessen sollten ·     Welche Rituale (zum Jahreswechsel) dich beim Loslassen unterstützen Show Notes: Mehr über Bardia Monshi erfährst du HIER. Follow us on ... Instagram Homepage YouTube WhatsApp: +43 664 88840236 Email: podcast@carpediem.life   Producers: Holger Potye & Agentur Soundfeiler    Wenn euch dieser Podcast gefallen hat, dann abonniert ihn, schreibt einen Kommentar, chattet mit uns via WhatsApp und gebt ihm 5 Sterne auf Apple Podcasts oder Spotify (Sterne-Wertung am Smartphone möglich). Wir freuen uns ganz besonders über Post, Anregungen und Ideen an: podcast@carpediem.life   Wusstest du schon, dass du jetzt via WhatsApp mit uns Kontakt aufnehmen kannst?   Das geht ganz einfach. Speichere die carpe diem-Podcast-Nummer +43 664 88840236 in deinen Kontakten ab.   Dann öffne dein WhatsApp und schick uns eine Nachricht. Egal ob als Text- oder Sprachnachricht.   Wir freuen uns immer über Lob, Kritik, Anregungen, Themenideen und Vorschläge für Wunschgäste. Und auf deine Stimme.

Mitschnitt des Sets von Bardia Salour vom Jahresausklang (FACK2024 Edition)

As the VP of Operations at Lief Labs, Bardia Eslami has played a pivotal role in shaping our company's growth, enhancing operational efficiency, and driving innovation. In this episode, he joins our host, Alegre Ramos, to discuss his journey at Lief—from starting as an intern to rising to his current leadership role.Over the years, Bardia has been an integral part of Lief's rapid expansion. In this conversation, he shares insights into key milestones and major projects he's been involved with. He also walks us through Lief's capabilities and explains how he leverages his expertise in operations to support brands.Disclaimer: The information provided in this podcast is for educational purposes only and is not intended as medical advice. The content shared in each episode should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult with a healthcare provider before starting any new supplement, making changes to your diet, or altering your fitness routine. Individual needs and responses to supplements may vary. Unless otherwise stated, the host and guests of this podcast are not medical professionals, and the opinions shared are based on personal experiences or general knowledge. Never disregard professional medical advice or delay seeking it because of something you heard on this podcast.

At the 2024 San Antonio Breast Cancer Symposium, Dr. Aditya Bardia, director of the Breast Oncology Program and Translational Research Integration at the UCLA Health Jonsson Comprehensive Cancer Center, presented results from the DESTINY-Breast06 study, showing that Enhertu (chemical name: fam-trastuzumab deruxtecan-nxki), also called T-DXd, was better than chemotherapy for metastatic, hormone receptor-positive, HER2-low or -ultralow breast cancer that grew after one or more hormonal therapy medicines. Listen to the episode to hear Dr. Bardia explain: results of the study what HER2-low and -ultralow breast cancer is whether people diagnosed with metastatic hormone receptor-positive, HER2-negative breast cancer should have additional HER2 testing

From minimal to groovy and playful - we take things a little easier. Special: Bardia Salour presents a new episode of the "Dub Archives" series Check: https://ebeatz.link/mps22bs **Tracklist** 1. Marko Fuerstenberg – Intro 2. Altone – Naturally Unnatural (Naturally flowing T. Fehlmann Remix) 3. Microwave Prince – Eternal Light (Remastered) 4. DIF – From Bassum nach Deepholz 5. Makam – Glacial Valley 6. coss & Peter Schumann – Mercer Island 7. Aril Brikha – Groove La Chord 8. Andrey Pushkarev – Frame 9. Justin Berkovi – It's On 10. C04, Kuuse – Trumm feat. C04 11. Mount Kimbie, Kai Campos – City Limits (Robert Hood Remix) 12. Mathias Kaden – Distant Horizon 13. Swayzak – Solemn Park Days

Have you ever been on a retreat? How can they shape your life? For how long have you been yearning for a space to fully and finally reset and center yourself? In this podcast episode, I discuss transformative retreats and choosing the best experience for your journey with Energy Sherpa Summer Bardia.  Thanks for listening, I'd love to connect with you over on Instagram and Facebook. Sign up for my Free Email Course. SHOW NOTES AND RESOURCES: Click here WEBSITE: www.sensitiveinnature.com

Welcome back to "Starting a Business Simplified!" In today's special "Summer Episode," we have the pleasure of talking with Summer Bardia, a dynamic entrepreneur who has transformed her career from a physician assistant to a holistic health practitioner specializing in energy movement and guided meditation. Summer shares her inspiring journey during COVID, her work at a gluten-free, vegan food place, and the invaluable lessons she learned from connecting with a new community. Our host, Suzy Wraines, draws valuable analogies to help guide listeners on their entrepreneurial paths. Summer dives deep into the importance of embracing flexibility, releasing constraints, and seeking guidance from the universe. She discusses the challenges and rewards of running your own business, balancing personal and professional life, and not letting perfection hold you back from helping others. From teaching energy classes outdoors to aiding the neurodivergent community, Summer's diverse experiences provide a wealth of knowledge for anyone on their own entrepreneurial journey. Join us as we explore how taking the first step, adapting to the flow of plans, and embracing collaboration can make all the difference. Plus, get ready for some inspiring insights into self-care, trauma energetics, and the power of community. Whether you're just starting out or looking for new ways to grow, this episode is packed with practical advice and heartfelt stories that will resonate with you. So, sit back, relax, and let's simplify the world of entrepreneurship together! Connect with Suzy: SuzyWraines.com Schedule a call: https://683519.17hats.com/p#/scheduling/ptcxpgvbdngwrshnkxktgrvpsbpkxvxd Subscribe to Business Success Accelerator Newsletter: https://www.startingabusinesssimplified.com/newsletter Join Business Builders Connect https://www.startingabusinesssimplified.com/business-community Join the Podcast Listener Community https://www.facebook.com/groups/startingabusinesssimplified

On this episode of Reel Insights, Sean Tajipour, the Mayor of Nerdtropolis, chats with Bardia Seiri from Grey's Anatomy, who stars in the new Netflix film 'Incoming.' Advance Screenings: https://nerdtropolis.com/tag/advance-screenings Nerdtropolis Facebook: https://www.Facebook.com/nerdtropolis Nerdtropolis Instagram: https://Instagram.com/nerdtropolis Nerdtropolis Twitter: https://Twitter.com/nerdtropolis Visit Our Website: https://Nerdtropolis.com

Welcome to the Pacific War Channel, where Craig and his co-host Gaurav delve into the dramatic North African campaign during World War II. In this gripping episode, they explore the Italian invasion of Egypt, the bold British counter-offensive known as Operation Compass, and the subsequent retreat of Italian forces. From strategic blunders to heroic advances, witness the fall of key locations like Bardia and Tobruk, the capture of thousands of Italian soldiers, and the eventual arrival of the German Afrika Korps led by General Erwin Rommel. Join us as we unravel the complexities of desert warfare, the logistical challenges faced by both sides, and the significant impact these battles had on the broader context of World War II. Support the channel by visiting our Patreon at www.patreon.com/thepacificwarchannel for exclusive content and more.

In this episode, Romy is joined by Bardia Rez, The Stop Drinking Coach, who's helping countless individuals redefine their relationship with alcohol. Bardia shares his personal journey with alcohol and the life-altering changes he embraced on his path to being alcohol free. Whether you're sober curious or questioning your drinking habits, this episode is for you.Romy also shares her own story of cutting out alcohol. With nearly a year and a half of going alcohol free, Romy opens up about how alcohol impacted her life and the remarkable improvements she's witnessed since removing it completely. This episode is about reclaiming your life, health, and happiness.Host: @healingwithromyGuest: @thestopdrinkingcoachCreative & Editing: @camilorafaelsierraMusic: @prodbydrazEngineering: @goldsauce24kClick Here to Work with Romy

It's the most special TIME in four years: February 29th — Leap Day! And what better TIME to catch up with Maxwell Keeper aka The Time Keeper? We find Maxwell busy at work, taking care of his brother-in-law Desmond's shop “Longo Watch Repair.” Who will walk through the doors on his most sacred day?

This evening we join Orual for her confrontation with Ansit, Bardia's widow.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/CC/NCPD/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/FHB865. CME/MOC/CC/NCPD/AAPA/IPCE credit will be available until January 25, 2025.Empowering Changes and Revolutionizing Treatment and Equity in Breast Cancer: Unlocking the Potential of Adjuvant CDK4/6 Inhibitors to Reduce the Risk of Recurrence and Improve Outcomes for Diverse Patient Populations With HR+/HER2- Early Breast Cancer In support of improving patient care, this activity has been planned and implemented by PVI, PeerView Institute for Medical Education, GRASP, and Living Beyond Breast Cancer. PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from Novartis Pharmaceuticals Corporation.Disclosure PolicyAll relevant conflicts of interest have been mitigated prior to the commencement of the activity.Faculty/Planner DisclosuresChair/PlannerAditya Bardia, MD, MPH, FASCO, has a financial interest/relationship or affiliation in the form of:Consultant and/or Advisor for Daiichi Sankyo Inc./AstraZeneca; Foundation Medicine, Inc.; Genentech, Inc.; Immunomedics, Inc./Gilead Sciences, Inc.; Lilly; Merck & Co., Inc.; Novartis Pharmaceuticals Corporation; Pfizer; Phillips Healthcare Corporation; Radius Health, Inc.; and Sanofi.Grant/Research Support from Daiichi Sankyo Inc./AstraZeneca; Genentech, Inc.; Immunomedics, Inc./Gilead Sciences, Inc.; Lilly; Merck & Co., Inc.; Novartis Pharmaceuticals Corporation; Pfizer; Radius Health, Inc.; and Sanofi.Planning Committee and Reviewer DisclosuresPlanners, independent reviewers, and staff of PVI, PeerView Institute for Medical Education, do not have any relevant financial relationships related to this CE activity unless listed below.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/CC/NCPD/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/FHB865. CME/MOC/CC/NCPD/AAPA/IPCE credit will be available until January 25, 2025.Empowering Changes and Revolutionizing Treatment and Equity in Breast Cancer: Unlocking the Potential of Adjuvant CDK4/6 Inhibitors to Reduce the Risk of Recurrence and Improve Outcomes for Diverse Patient Populations With HR+/HER2- Early Breast Cancer In support of improving patient care, this activity has been planned and implemented by PVI, PeerView Institute for Medical Education, GRASP, and Living Beyond Breast Cancer. PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from Novartis Pharmaceuticals Corporation.Disclosure PolicyAll relevant conflicts of interest have been mitigated prior to the commencement of the activity.Faculty/Planner DisclosuresChair/PlannerAditya Bardia, MD, MPH, FASCO, has a financial interest/relationship or affiliation in the form of:Consultant and/or Advisor for Daiichi Sankyo Inc./AstraZeneca; Foundation Medicine, Inc.; Genentech, Inc.; Immunomedics, Inc./Gilead Sciences, Inc.; Lilly; Merck & Co., Inc.; Novartis Pharmaceuticals Corporation; Pfizer; Phillips Healthcare Corporation; Radius Health, Inc.; and Sanofi.Grant/Research Support from Daiichi Sankyo Inc./AstraZeneca; Genentech, Inc.; Immunomedics, Inc./Gilead Sciences, Inc.; Lilly; Merck & Co., Inc.; Novartis Pharmaceuticals Corporation; Pfizer; Radius Health, Inc.; and Sanofi.Planning Committee and Reviewer DisclosuresPlanners, independent reviewers, and staff of PVI, PeerView Institute for Medical Education, do not have any relevant financial relationships related to this CE activity unless listed below.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/CC/NCPD/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/FHB865. CME/MOC/CC/NCPD/AAPA/IPCE credit will be available until January 25, 2025.Empowering Changes and Revolutionizing Treatment and Equity in Breast Cancer: Unlocking the Potential of Adjuvant CDK4/6 Inhibitors to Reduce the Risk of Recurrence and Improve Outcomes for Diverse Patient Populations With HR+/HER2- Early Breast Cancer In support of improving patient care, this activity has been planned and implemented by PVI, PeerView Institute for Medical Education, GRASP, and Living Beyond Breast Cancer. PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from Novartis Pharmaceuticals Corporation.Disclosure PolicyAll relevant conflicts of interest have been mitigated prior to the commencement of the activity.Faculty/Planner DisclosuresChair/PlannerAditya Bardia, MD, MPH, FASCO, has a financial interest/relationship or affiliation in the form of:Consultant and/or Advisor for Daiichi Sankyo Inc./AstraZeneca; Foundation Medicine, Inc.; Genentech, Inc.; Immunomedics, Inc./Gilead Sciences, Inc.; Lilly; Merck & Co., Inc.; Novartis Pharmaceuticals Corporation; Pfizer; Phillips Healthcare Corporation; Radius Health, Inc.; and Sanofi.Grant/Research Support from Daiichi Sankyo Inc./AstraZeneca; Genentech, Inc.; Immunomedics, Inc./Gilead Sciences, Inc.; Lilly; Merck & Co., Inc.; Novartis Pharmaceuticals Corporation; Pfizer; Radius Health, Inc.; and Sanofi.Planning Committee and Reviewer DisclosuresPlanners, independent reviewers, and staff of PVI, PeerView Institute for Medical Education, do not have any relevant financial relationships related to this CE activity unless listed below.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/CC/NCPD/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/FHB865. CME/MOC/CC/NCPD/AAPA/IPCE credit will be available until January 25, 2025.Empowering Changes and Revolutionizing Treatment and Equity in Breast Cancer: Unlocking the Potential of Adjuvant CDK4/6 Inhibitors to Reduce the Risk of Recurrence and Improve Outcomes for Diverse Patient Populations With HR+/HER2- Early Breast Cancer In support of improving patient care, this activity has been planned and implemented by PVI, PeerView Institute for Medical Education, GRASP, and Living Beyond Breast Cancer. PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from Novartis Pharmaceuticals Corporation.Disclosure PolicyAll relevant conflicts of interest have been mitigated prior to the commencement of the activity.Faculty/Planner DisclosuresChair/PlannerAditya Bardia, MD, MPH, FASCO, has a financial interest/relationship or affiliation in the form of:Consultant and/or Advisor for Daiichi Sankyo Inc./AstraZeneca; Foundation Medicine, Inc.; Genentech, Inc.; Immunomedics, Inc./Gilead Sciences, Inc.; Lilly; Merck & Co., Inc.; Novartis Pharmaceuticals Corporation; Pfizer; Phillips Healthcare Corporation; Radius Health, Inc.; and Sanofi.Grant/Research Support from Daiichi Sankyo Inc./AstraZeneca; Genentech, Inc.; Immunomedics, Inc./Gilead Sciences, Inc.; Lilly; Merck & Co., Inc.; Novartis Pharmaceuticals Corporation; Pfizer; Radius Health, Inc.; and Sanofi.Planning Committee and Reviewer DisclosuresPlanners, independent reviewers, and staff of PVI, PeerView Institute for Medical Education, do not have any relevant financial relationships related to this CE activity unless listed below.

Welcome to Dry January... As we close the curtains on our 2023 countdown journey, I extend my heartfelt gratitude to each one of you who joined us for every episode. Your time and attention mean the world to me. My aim has been to introduce captivating guests who've not only enriched your 2023 but also left you with insights that will continue to resonate long after this year fades. Thank you for allowing me to be part of your growth and learning journey. Here's to the wisdom gained and the lessons cherished, making an enduring impact on your path ahead. The #1 most listened-to podcast episode of 2023 is with Bardia Rezaei. From a dysfunctional upbringing to a high-functioning binge drinker to turning his life around, Bardia shares his incredible journey, what he's learned along the way, and now as a Stop Drinking Coach and Life Coach, how he can help you reclaim your life and sustain sobriety. Happy New Year! ⁠⁠⁠⁠⁠⁠⁠⁠⁠Join the Live Better Now Run Club⁠⁠⁠⁠⁠⁠⁠⁠⁠ FREE Whoop Strap: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠http://join.whoop.com/zachrance⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Get my book "Live Better Now" on ⁠⁠Amazon⁠ ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://a.co/d/8zFqZXD⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Connect with me: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Instagram⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Website⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Facebook⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ ⁠⁠⁠ --- Send in a voice message: https://podcasters.spotify.com/pod/show/zachrance/message

Pourtant, que la montagne est belle ! En 2003, l'ONU a déclaré le 11 décembre Journée internationale de la montagne. Les montagnes ne sont pas qu'un terrain de jeu ou une jolie carte postale. Elles sont les sources d'alimentation en eau douce de la moitié de la population mondiale. Elles jouent un rôle essentiel dans les équilibres écologiques de la planète. Si les montagnes semblent indestructibles, elles sont vulnérables. Le réchauffement provoque la fonte des glaciers, et cause des dommages à bien des espèces qui avaient un dernier refuge en montagne, loin de l'expansion humaine. L'hypertourisme et l'exploitation abusive des ressources naturelles et beaucoup d'autres activités humaines nuisent plus ou moins directement aux montagnes. Pour célébrer la journée mondiale des montagnes, Marc Mortelmans nous parle de celles qu'il connaît le mieux, les Andes, où il a travaillé comme guide d'expéditions pendant 6 ans.  Après les condors et les camélidés latinos, ce tout dernier épisode de la saison 2 est dédié aux autres animaux et plantes des Andes : Armadillo (Tatou), Viscacha, Puma, Quinoa et Llareta. Ces épisodes sont présentés par Kris de Bardia, qui a accepté de prendre la place de l'intervieweur. Kris, vous vous souvenez ? ce guide animalier qui était venu nous raconter le tigre du Népal , les animaux de l'arctique de l'antarctique et ceux de Laponie, en début de saison 2.    ______ On aime ce qui nous a émerveillé … et on protège ce qu'on aime. ______ Découvrir tout l'univers Baleine sous Gravillon, et Mécaniques du Vivant sur France Culture : https://baleinesousgravillon.com/liens-2 Soutenir notre travail, bénévole et sans pub : https://bit.ly/helloasso_donsUR_BSG http://bit.ly/Tipeee_BSG https://bit.ly/lien_magq_lilo_BSG Nous contacter pour une conférence, un partenariat ou d'autres prestations ou synergies : contact@baleinesousgravillon.com

Aditya Bardia, MD, MPH - When HER2 Is Low or Negative: Emerging Evidence on Antibody-Drug Conjugates for Hormone Receptor-Positive and Triple-Negative Breast Cancers

Aditya Bardia, MD, MPH - When HER2 Is Low or Negative: Emerging Evidence on Antibody-Drug Conjugates for Hormone Receptor-Positive and Triple-Negative Breast Cancers

At the European Society for Medical Oncology (ESMO) 2023 Congress Aditya Bardia, MD, MPH, presented results from the TROPION-Breast01 trial, which is comparing a new antibody-drug conjugate, datopotamab-deruxtecan (dato-DXd), to doctors' choice of chemotherapy for inoperable or metastatic, hormone receptor-positive, HER2-negative breast cancer that had grown while being treated with hormonal therapy and also had been treated with chemotherapy. Listen to the podcast to hear Dr. Bardia explain: what an antibody-drug conjugate is the design of the TROPION-Breast01 study and the first results dato-DXd side effects how dato-DXd might fit into the current treatment landscape for metastatic breast cancer

This is Part 8 of our series looking at the Kokoda Campaign, Battle of Isurava, the 53rd Battalion, how they fought and how they were prepared to fight. This episode looks at the Principles of Training and how they were(n't) applied by New Guinea Force.  We compare it with the preparation of the 6th Division in preparation for it's first battle at Bardia.  Bardia illustrates what right looks like for preparing troops for combat. Check out the show notes for the podcast for all of the information that we cover in this episode as well as the images and other details that didn't make it into the podcast.

Inside the Issue: Current and Future Management of ER-Positive Metastatic Breast Cancer After Disease Progression on a CDK4/6 Inhibitor | Faculty Presentation 1: Current Strategies for Previously Treated ER-Positive Metastatic Breast Cancer (mBC) — Aditya Bardia, MD, MPH CME information and select publications

A few years ago, a Philadelphia area Apple store featured a display in which a vibrant rainbow of the latest iPhones broke through a greyscale crowd of people. What was particularly striking about the advertisement wasn't the use of contrast nor that this was not some thinly veiled “Pride” month display. The multi-colored iPhones were positioned like veils, so that no face, or even part of a face, could be seen.  If Apple hoped the display would inspire new eagerness to join the technicolor life awaiting customers behind their screens instead, by veiling human faces, the campaign unveiled the depersonalizing effects of our most ubiquitous technologies, especially smartphones, social media, and the internet. This combination–which makes up our brave new world of new media–regularly functions as barriers to other people and to the outside world, behind which we hide. Think of the socially anxious teen whose face is “glued” to the screen or think of the man who surfs for sexually explicit content online. New media offers them and others a place of anonymity, where they can live and move and have their being, unencumbered by others.   Our “digital veils” also function as a source of power and control, in a way depicted long ago in C.S. Lewis's classic, Till We Have Faces. The main character and narrator in the story is Orual, the unattractive and tomboyish older sister of the goddess Psyche. Orual convinces Psyche to disobey her husband, the god Cupid, who then banishes Psyche and ends their marriage. As a result, Orual decides to live out the rest of her days wearing a black veil.   The veil, which starts off as “a sort of treaty made with [her] ugliness,” quickly becomes a form of power and control. Whereas her ugliness and mannishness caused others to disregard her, the veil gives her a kind of power over others. Her father, the king, takes her seriously, suitors flock to her, and enemies respect her. By shrouding her face in mystery, the veil even led some to imagine she was a dazzling beauty or even a spirit.  Like Orual's veil, new media can become a kind of digital veil offered that enables us to hide from others, influence their perceptions of us, and control our personal images. Social media especially functions in this way. We build profiles of perfectly lighted and cropped snapshots, snippets of the latest vacation, nights out with friends, and personal projects. Through this, we shape others' perceptions of us, giving them the impression that our lives are constantly happy, fun, and productive. Through the process, some even become online “influencers,” influencing what others post, buy, or do.    Ultimately, the veil's power and control are short lived. Despite their apparent advantages, digital veils leave us anxious and unknown. As one popular YouTuber, Samuel Bosch, shared in a video earlier this year:   I sometimes think that many of you have this very wrong impression that I'm always happy, traveling and productive, that I can buy anything I want to, get any job I desire, or date whoever I want to.   Yet, for all his success as an online influencer, MIT Ph.D. student, and tech entrepreneur, Bosch is, admittedly, unhappy.   This is because we were made by God to be known. It is, in fact, a central conclusion of the psalmist David that, wherever we go, we are known.    Where shall I go from your Spirit?     Or where shall I flee from your presence? If I ascend to heaven, you are there!     If I make my bed in Sheol, you are there! If I take the wings of the morning     and dwell in the uttermost parts of the sea, even there your hand shall lead me,     and your right hand shall hold me. If I say, “Surely the darkness shall cover me,     and the light about me be night,” even the darkness is not dark to you;     the night is bright as the day,     for darkness is as light with you.  The psalm begins with the definitive statement that God has indeed searched and known him and ends with an invitation to God to search and know him. That's the tension, isn't it? Years ago, as I wrestled through Psalm 139 with a group of college students facing graduation, they articulated that tension, of both comfort and fear, that they are always known and always seen.  Ultimately, all veils are an illusion. They may hide us from others, but they cannot hide us from God, who not only sees us and knows us, but created us to be seen and known both by and for others.    Toward the end of Lewis' masterpiece, Orual visits the widow of her beloved servant Bardia. Upset that the widow might be jealous of the time Bardia spent with her, Orual jumps up in a burst of rage and lifts her veil to show the widow that she had nothing of which to be jealous. However, rather than being met with fear or hatred or disregard, Orual is met with the widow's compassion and kindness. Orual finds herself no longer alone, no longer unknown, no longer unloved.  Like Orual, we can lay down our digital veils. When we do, we will find that we are already truly seen, truly known, and truly loved by God, and we can be truly seen, known, and loved by others.  This Breakpoint was co-authored by Jared Eckert. For more resources to live like a Christian in this cultural moment, go to breakpoint.org. 

Kris est un bourlingueur au départ. Il y a 20 ans, au cours d'une rando en forêt au Népal, il rencontre sans s'y attendre un tigre du Bengale. La rencontre vire à l'expérience mystique et infléchit le cours de sa vie.  Kris pose son backpack à Bardia, près du grand parc national du même nom. Il y achète un hôtel et va y travailler 20 ans comme guide animalier.  Armé d'un simple bâton, il pratique l'approche à pied des animaux. La plus noble, la plus respectueuse, la plus enrichissante. Il permet à des milliers de curieux de rencontrer le rarissime rhinocéros unicorne, le tigre du Bengale, son animal totem sur lequel il a écrit un livre, le léopard, l'éléphant d'Asie et bien d'autres animaux du Terrai, les savanes et forêts du sud du Népal.  _______ On aime ce qui nous a émerveillé … et on protège ce qu'on aime. _______ Découvrir tout l'univers Baleine sous Gravillon, et Mécaniques du Vivant sur France Culture : https://baleinesousgravillon.com/liens-2 Soutenir notre travail, bénévole et sans pub : https://bit.ly/helloasso_donsUR_BSG http://bit.ly/Tipeee_BSG https://bit.ly/lien_magq_lilo_BSG Nous contacter pour une conférence, un partenariat ou d'autres prestations ou synergies : contact@baleinesousgravillon.com 

Pour écouter la série entière : https://bit.ly/kris-bardia3_BSG https://bit.ly/kris-bardia2_BSG https://bit.ly/kris-bardia1_BSG 3e et dernier voyage avec Kris de Bardia, l'ami guide animalier. Après le Népal, l'Arctique et l'Antarctique, Kris nous emmène cette fois en Laponie, cette région boréale à cheval sur plusieurs pays : Norvège, Suède, Finlande, Russie. Les Lapons, qui s'appellent eux-mêmes les Sames ou Samis, ne survivraient sans le renne. Kris nous raconte cet animal prodigieux, adapté aux grands froids. Dans les étendues glacées, dans la toundra et la taïga, nous rencontrerons le glouton, alias carcajou au Québec, alias wolverine pour les anglophones. C'est le géant mal aimé, réputé féroce et "tueur en série" de la famille des mustelidés (loutre, fouine, martre belette, blaireau...).  Les éleveurs de rennes constatent qu'il tue autant que possible, beaucoup plus qu'il ne peut manger tout de suite. Pourquoi? Kris va nous éclairer. Une situation comparable avec celle du loup en France, redouté par les éleveurs de moutons. Nous parlerons aussi du loup, et du lynx et même des aurores boréales: comment naissent-elles? _______   On aime ce qui nous a émerveillé … et on protège ce qu'on aime. _______ Découvrir tout l'univers Baleine sous Gravillon, et Mécaniques du Vivant sur France Culture : https://baleinesousgravillon.com/liens-2 Soutenir notre travail, bénévole et sans pub : https://bit.ly/helloasso_donsUR_BSG Nous contacter pour une conférence, un partenariat ou d'autres synergies : contact@baleinesousgravillon.com _______ Interview : Marc Mortelmans Rédaction en chef : Guillaume Lassalle Graphisme : Elouan Plessix Montage / notices / programmation : Zeynab Tamoukh, Albane Couterot, Paul Lavigne

Alan is joined by Farouk, quantum physicist, and Bardia, astronomer to talk about Artificial Intelligence. Is there any need to fear? Is it already too late? Conversation moves on to the block chain and crypto currencies.Music: Living in Blood - Sons of VenusSubscribe, rate, and review the show!Support this podcast at — https://redcircle.com/porch-talk/exclusive-contentAdvertising Inquiries: https://redcircle.com/brandsPrivacy & Opt-Out: https://redcircle.com/privacy

In this episode of Media Monsters Nick, Jim, Alex, Duran and Bardia have a pleasant and wide-ranging conversation about director Stanley Kubrick. Music Credits Opening Stardrive by | e s c p | https://escp-music.bandcamp.com Music promoted by https://www.free-stock-music.com Creative Commons / Attribution 4.0 International (CC BY 4.0) https://creativecommons.org/licenses/by/4.0/ Closing Parallel Synthesis by | e s c p | https://escp-music.bandcamp.com Music promoted by https://www.free-stock-music.com Creative Commons / Attribution 4.0 International (CC BY 4.0) https://creativecommons.org/licenses/by/4.0/

This week we have Bardia Rezaei, a Sobriety and Life Coach - who at his lowest was drinking 4-6 bottles of wine a day. With real experience and his own personal approach, he specializes in helping people learn how to successfully stop drinking. If you're looking to change how you socialize, feel you need to take inventory of how you're drinking or have interest in lifestyle resets, check it out.In addition to coaching on addiction & sobriety, Bardia provides specialized coaching as well by developing a bulletproof mindset, building confidence & increasing self-esteem to love the person looking at you in the mirror. He teaches skills for reducing anxiety to feel more calm and present. Applies techniques for mental / emotional regulation so you can stay "in the pocket" during his stress situations, building personal power so you can freely take action without worry, judgement or fear. And helps facilitate time management & organization to enhance productivity and tangible results. And checkout Magnesium Breakthrough by BiOptimizers for an exclusive offer at magbreakthrough.com/zaddy. In addition to the discount you get by using promo code zaddy, you can unlock special gifts with purchase with retail values of at least 20 dollars. Athletic Greens giving a FREE 1 year supply of immune-supporting Vitamin D AND 5 FREE travel packs with your first purchase. All you have to do is visit athleticgreens.com/zaddy. You can find him at: IGtiktokTwitterPodcastLinkedin Subscribe or keep tuning in at: IGTikTokYouTubeThelukecook.comNewsletterINTRO   3:10 The beginning - 4-6 bottles of wine a day. Social acceptance and norms of drinking.The effects that go unnoticed.    10:00 The science confirming alcohol is an actual poison. Evolutionary reactions - dopamine.   15:00 Effects on dopamine over time. Gabba deficits.   18:30 What happens when you take away the good time target or weeks reward? What you discover. Returning home to yourself. Choosing the wrong god.   26:00 Varying degrees of use and how to address that. Stats and facts.   30:00 Accessing the pain in order to stop. How to know if it's getting in the way.   36:00 Self-awareness. The best decision of your life - Bardia's at least.   43:00 Handling the social adversity. Monk Mode. Re-training how to party.   49:30 On the outside looking in - can be quite nice. Bardia's morning routine. Manifestation & meditation. The feeling and the thing.See omnystudio.com/listener for privacy information.

Today's guest is Bardia Rezaei, The Stop Drinking Coach! Bardia is a Sobriety and Life Coach that specializes in helping people learn how to stop drinking successfully so they can step into the next chapter of their lives and begin fulfilling their potential. He doesn't believe people who struggle with alcohol (alcohol use disorder or alcoholism) are destined to attend daily meetings for the rest of their lives and continually live in the shadow of their addiction. He opens up about his personal struggles with alcoholism both in his family and in his own life, what he's learned about dopamine and our brain's response to consuming alcohol, and how quitting drinking can benefit you spiritually. ◽️ Follow Bardia on Instagram ◽️ Follow him on TikTok ◽️ Work With The Stop Drinking Coach

Today's guest is Bardia Rezaei. He is a Sobriety and Life Coach who teaches people how to quit drinking alcohol so they can step into the next chapter of their life and begin fulfilling their potential. Currently, he is on a mission to create a revolutionary system that helps people who struggle with alcohol, transform their life mentally, emotionally and spiritually.   Listen to Bardia's "The Stop Drinking Coach" Podcast Apple Spotify   This Episode's Key Topics Having a "one day at a time" mentality Bardia's story and journey to sobriety What would Bardia ask his deceased father if he could? How Bardia's uncle impacted his life when his father passed away How do you know when alcohol is problematic? The dangers of alcohol and how it's normalized What makes us want to live in a carefree world? Why we should try to understand our trauma How Bardia started his brand and coaching Bardia's biggest struggle as a coach A day in the life of Bardia Rezaei Bardia's coaching program and platforms What does "thriving" mean to Bardia?   Connect with Bardia Instagram TikTok   Connect with CJ Finley: CJ's Instagram   CJ's YouTube THRIVEONLIFE Podcast Instagram THRIVEONLIFE Website  

Í öngum mínum erlendis.. yrki ég skemmsta daginn.. Mjúk lending í Nepal. 12. feb, 16. feb, 17. feb, 28. feb. Lumbini, Bardia frumskógur, Vipassana inngangur og útgangur. pt. 2 soon come!

Discussing the EMERALD Phase III study which resulted in the FDA approval of the first oral selective estrogen receptor degrader (SERD) after demonstrating statistically significant and clinically meaningful benefit in postmenopausal women and men, with ER+, HER2- metastatic breast cancer patients, post progression in first line with endocrine therapy and CDK4/6i. In discussion with the lead author, Dr. Aditya Bardia - Associate Professor at Massachusetts General Hospital - Harvard Medical School.     Website: http://www.oncbrothers.com/ Twitter: https://twitter.com/oncbrothers Contact us at info@oncbrothers.com

Bardia Rezaei is here today, part of Dry January. From a dysfunctional childhood to a high-functioning binge drinker to turning his life around, Bardia shares his incredible journey, what he's learned along the way and now as a Stop Drinking Coach and Life Coach, how he can help you reclaim your life and sustain sobriety. Find him on Tik Tok @stopdrinkingcoach Look for him on Instagram @thestopdrinkingcoach And check out his website: https://www.thestopdrinkingcoach.com/ My new book, "Live Better Now" is out now on Amazon... I wrote this book as a companion piece to everything I talk about and have talked about for the last couple of years in the health, wealth and happiness space. It's suitable for all ages and offers practical advice on focusing on what matters most to improve your life now!. Amazon: amzn.to/3csfVGw Zach Rance, Certified Life Coach | Certified Nutritionist Questions, Comments, or Business Inquiries Visit: LifeCoachZach.com Find me on Instagram: @zachrancey --- Send in a voice message: https://anchor.fm/zachrance/message

Farouk, Egyptian quantum physicist, and Bardia, Iranian astronomer weigh in on the state of the world. Women's rights is taking place in Iran, so Bardia shares first hand experience on the matter. The conversation shifts towards war, and Farouk answers to supply chain issues that effects Egypt.Support this podcast at — https://redcircle.com/porch-talk/exclusive-contentAdvertising Inquiries: https://redcircle.com/brandsPrivacy & Opt-Out: https://redcircle.com/privacy

In this weeks episode Julia speaks with Bardia, the stop drinking coach! You can follow along at: Blazik IG: @itsblazik TikTok: sober.guy.journal Julia: IG: @that1soberfriend TikTok: @that1soberfriend Bardia: IG: @thestopdrinkingcoach TikTok: @stopdrinkingcoach Intro Music: @TarikTrotter Song: Tarik - Infinite

Tigers are making a remarkable comeback in Nepal. The small Himalayan nation is on track to become the first country to double its wild tiger population in the last decade. A new census will be released on International Tiger Day (29th of July). The recovery is the result of tough anti-poaching measures that have involved the military and the local community. Other iconic species including rhinos and elephant populations have also increased. But this has come at a cost, there has been an increase in tiger attacks on humans. Rebecca Henschke travels to Bardia national park, to find out what's behind the conservation success and what it means for the community living with the Tigers. Presented by Rebecca Henschke Produced by Kevin Kim and Rajan Parajuli, with the BBC Nepali team Studio mix by Neil Churchill Production coordinators Gemma Ashman and Iona Hammond Editor Penny Murphy

This is the free first half of Office Hours. Watch or listen to the full two hours with more Sandy and Bardia, a MAJOR JIM BAKKER BOMBSHELL testimony from his former bandleader Mark Dowdy, and get tons of other stuff at patreon.com/officehoursliveIt was a comedy goldmine this week with comedians Sandy Honig and Bardia Salimi, plus a MAJOR COVID BOMBSHELL from Tim.Join Doug and Matt for a special Office Hours Movie Night in Chicago on 7/21 - get tickets at bit.ly/ohlmovienight.See the two Tims live on tour this summer! Get tickets at timheidecker.com/liveListen to and buy Tim's new album "High School" NOW at ffm.to/thhighschoolFind everything else at officialofficehours.com See acast.com/privacy for privacy and opt-out information.